Resource library search

Abstract submissions close in one week on Friday 17 February 2023 (23:59 GMT) for Candida and Candidiasis 2023, taking place 13–17 May 2023 in Montréal, Canada for the first time.

Down in the depths of the ocean, scientists believe they may have discovered a treasure trove. Not a sunken chest filled with gold coins and lost riches, but perhaps something even more valuable. A soon to be published study has revealed that the gut microbiomes of deep-sea fish are teeming with new antimicrobial molecules that could fight common foodborne infections. The findings shed a new light on this previously untapped resource and could one day pave the way for new antimicrobial medicines.

Researchers have used genomic sequencing tools to investigate antimicrobial resistance in raw milk from dairy farms. They identified bacteria with resistance to several commonly-used antibiotics, arguing the importance of using precision genomics tools in the next generation of food safety controls to provide more detailed risk assessments. 

British Yeast Group 2022: From Genomes to Cells took place on 7–9 September 2022 and was held at the University College London, UK.

Abstract submission closes on Tuesday 30 August 23:59 BST for Understanding and Predicting Microbial Evolutionary Dynamics. The Focused Meeting will take place 22–23 November 2022 at Hyatt Regency Manchester, UK.

We are pleased to announce an extension to the abstract submission deadline for Gut Microbiome and Mucosa-Associated Infectious Disease: Mining for Antimicrobials and Postbiotics with Therapeutic Potential. Abstracts for offered oral and poster presentations can now be submitted until Wednesday 31 August, 2022 23:59 BST.

The final delegate registration deadline to attend Genomes of Microbiome is Thursday 11 August 2022, but may close earlier if the meeting reaches capacity. Please register as soon as possible to secure your place.

We are pleased to announce that delegate registration for ‘Gut Microbiome and Mucosa-Associated Infectious Disease: Mining for Antimicrobials and Postbiotics with Therapeutic Potential’ is now open.

Early bird registration rates for ‘Genomes of Microbiomes' closes on Thursday 4 August. Register now to enjoy the discounted rate for your attendance.

The Early Bird registration deadline for British Yeast Group 2022: From Genomes to Cells is Friday 29 July 2022 at 23:59 BST (UK Time). Register now to secure your discounted registration for the meeting, taking place 7–9 September 2022, at University College London, UK.

Protein Secretion at the Host-Pathogen Interface is pleased to announce an extension to the abstract submission deadline. Abstracts for offered oral and poster presentations can now be submitted until Monday 15 August, at 23:59 BST.

Cryptosporidiosisis a disease caused by infection of a host by the parasite Cryptosporidium, usually C. hominis or C. parvum, and is often associated with contaminated food or farm animal contact. Whilst diarrhoea is a common symptom of infection in the acute phase, longer-term health risks to the majority of the population in industrialised countries are considered low. However, increasing volumes of evidence suggest that long-term impacts of infection are still present up to 28 months after infection, potentially seriously affecting patients’ quality of life – an understanding which researchers hope will be reflected in public health measures in the future.

We are pleased to announce our first Focused Meeting of 2023, Vaccines as Tools to Combat Antimicrobial Resistance, in association with BactiVac, the Bacterial Vaccines Network. The meeting will take place on 27—28 February 2023 at Edgbaston Park Hotel and Conference Centre in Birmingham, UK.

Staphylococcus aureus are opportunistic, Gram-positive bacteria, which are responsible for a large number of hospital and community-acquired infections. Current treatment options are limited to antibiotics, but with a rising number of multidrug-resistant strains the need to find alternative therapies is becoming increasingly apparent. One such treatment is via the inhibition of communication between the bacteria. Although these therapy options have previously been limited, research by a team from the University of Copenhagen, Denmark has found that probiotics already available may offer the ability to reduce disease severity of S. aureus.

Antimicrobial resistance (AMR) is an increasing global threat which requires novel therapies with which to fight resistant infections. A recent study by researchers at the University of Oxford, UK hopes to have found that such a method may be through the infiltration of bacterial social cooperation.  

Hepatitis A virus (HAV) is a unique, liver-tropic picornavirus that has not been as widely studied as many other picornaviruses, despite having a significant impact on global health. Highly effective and safe vaccines are available, yet their use is not universal and since 2016 the US alone has seen over 24,000 hospitalisations and 400 deaths due to Hepatitis A. Currently there’s no treatment available for severe cases other than liver transplantation, but research at the University of North Carolina at Chapel Hill supervised by Prof. Stanley M. Lemon has identified an essential step in HAV infection, a finding which offers hope for the development of future therapeutics.

British Yeast Group 2022 is pleased to extend the abstract submission deadline. The deadline for all abstracts to be submitted for the meeting is 6 June 2022, at 23:59 BST.
 

Bacteria found on the leaves of common UK tree species may remove toxic carbon monoxide (CO) from the air, according to researchers from the University of Warwick, UK.